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ABSTRACT
Synthetic genome recoding is a new means of gen-
erating designed organisms with altered pheno-
types. Synonymous mutations introduced into the
protein coding region tolerate modifications in DNA
or mRNA without modifying the encoded proteins.
Synonymous genome-wide recoding has allowed
the synthetic generation of different small-genome
viruses with modified phenotypes and biological
properties. Recently, a decreased cost of chemically
synthesizing DNA and improved methods for assem-
bling DNA fragments (e.g. lambda red recombination
and CRISPR-based editing) have enabled the con-
struction of an Escherichia coli variant with a 4-Mb
synthetic synonymously recoded genome with a re-
duced number of sense codons (n = 59) encoding
the 20 canonical amino acids. Synonymous genome
recoding is increasing our knowledge of microbial in-
teractions with innate immune responses, identifying
functional genome structures, and strategically ame-
liorating cis-inhibitory signaling sequences related
to splicing, replication (in eukaryotes), and complex
microbe functions, unraveling the relevance of codon
usage for the temporal regulation of gene expression
and the microbe mutant spectrum and adaptability.
New biotechnological and therapeutic applications
of this methodology can easily be envisaged. In this
review, we discuss how synonymous genome recod-
ing may impact our knowledge of microbial biology
and the development of new and better therapeutic
methodologies.
SYNONYMOUS MUTATIONS AND GENOME CODING
The genetic code is common to all organisms and exten-
sively redundant. Based on the nature of triplet encoding
and the fact that there are four different nucleotides, only
43 = 64 different codons are possible. Of these possible 64
codons, 61 are sense codons, coding for 20 amino acids
and 3 are stop codons, coding for termination of transla-
tion. Eighteen of these amino acids are encoded by more
than one synonymous codon. Consequently, a given amino
acid might be encoded by one, two, three, four or six dif-
ferent codons (Figure 1). Importantly, the observed ratios
of synonymous codons are highly non-random (1). This
phenomenon is termed codon usage bias. Foreign protein
expression in Escherichia coli is well-known to be influ-
enced significantly by the presence or absence of uncommon
codons, and heterologous protein expression often requires
coding sequence modification (2).
A suggested model of codon usage bias is that abun-
dant codons correlate with the abundances of isoaccept-
ing tRNAs, which correlate with protein production levels
(3). However, tRNA availability is not the sole determinant
of protein production (4). Synonymous codon mutations
can impact many molecular phenotypes, including tran-
scription modifications (5,6), translation initiation (7–9),
translation elongation (10,11), translation accuracy (12,13),
RNA stability (14), RNA structure and folding (8,15), RNA
splicing (16,17), RNA toxicity (18) and cotranslational fold-
ing (23). In the case of eukaryotes, synonymous substi-
tutions can affect chromatin organization (19), enhancer
functions (20,21) and microRNA targeting (20,22). Due to
the impact of synonymous mutations on molecular pheno-
types, it is not difficult to assume that they are under se-
lective pressure. Moreover, natural selection has generated
unequal codon usage across genes and genomes (24,25).
Accordingly, synonymous nucleotide positions have been
modelled by genome-wide mutational processes during evo-
lution (26,27). Synonymous codon usage is neither random
nor neutral (28–30). Organisms and different genes from
the same organism include specific codons at different fre-
quencies (31). Human codon frequencies for synonymous
codons are not equal (Figure 1). Synonymous codon fre-
quencies varies among different taxa, with codon usage in
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Figure 1. The standard genetic code and codon bias. Each amino acid is encoded by multiple codons, except methionine and tryptophan. On the right
are the human frequencies per thousand for each codon. The Kazusa database (http://www.kazusa.or.jp/codon/) was used to compile human codon usage.
Codons carrying CpG and UpA dinucleotides are underrepresented.
mammals differing from that in bacteria or insects. Synony-
mous codons may also play distinct roles at different sites
in the genome, and epistatic interactions may occur among
codons within and between genes (2). Although this review
mainly deals with prokaryotes and viruses, it is worthy to
mention that genome-wide association studies and ulterior
functional analyses have recently shown that synonymous
substitutions can impact complex human diseases, such as
cancer (32) and autism (33).
Synonymous genome recoding alters not only codon us-
age, but also codon-pair usage, and dinucleotide frequency
(e.g. CpG/UpA) (reviewed in (34)). Recently, it has been de-
scribed that efficient mRNA translation is also determined
by a triplet-of-triplet genetic code, that is, translation of
a given codon is influenced by the two preceding codons
and that given codon (56). In addition to codon usage bias,
which has been thoroughly studied in many species, codon-
pair frequencies (termed codon-pair bias) are different in
different organisms. In any given genome, different frequen-
cies of codon-pairs are found than would be expected based
on the individual codon usage bias of that genome (re-
viewed in (31)). Codon-pair usage bias was first described
in bacteria (35), and then in all studied organisms (30). An
analysis of 14 795 human genes showed that some synony-
mous codon-pairs are used more or less frequently than ex-
pected (36). For example, based on the codon frequencies,
the amino acid pair Ala–Glu would be expected to be en-
coded equally as frequently by GCCGAA and GCAGAG.
However, even though the codon-pair GCCGAA contains
the most frequent Ala codon, it is strongly underrepre-
sented, as it is used only one-seventh as often as GCAGAG.
Analysis of an extended data set of 35 770 human mRNA
sequences had similar findings (37). Whether codon-pair us-
age bias is shaped by selection is controversial. Looking
at the underrepresented codon-pair GCCGAA, we easily
notice that a CpG dinucleotide is generated between the
third base of the first codon and the first base of the ac-
companying codon. Many of the underrepresented human
codon-pairs generate CpG dinucleotides (38). CpG dinu-
cleotides are less frequent than expected in both humans
and other mammals (Figure 1) (39). The mechanistic rea-
sons for this underrepresentation are unclear. Compared
to other dinucleotides, the mutation rate of the CpG mo-
tif is at least 10-fold higher, especially in higher primates
(40), likely due to cytosine methylation resulting in deam-
ination to thymine (40). Moreover, 5-methylcytosine in the
context of the CpG sequence is an epigenetic mechanism as-
sociated with transcriptional repression (41,42). These find-
ings strongly suggest that it is very difficult to distinguish be-
tween codon-pair usage bias and dinucleotide frequencies.
Because codon-pair bias and dinucleotide frequency are
inevitably connected, whether one is generating the other
is still in question (37,38,43,44). Interestingly, most mam-
malian RNA viruses have low frequencies of CpGs (45,46).
Furthermore, viruses with high CpG frequencies may be
more recognizable by pathogen innate immune sensors (47–
50). A broad spectrum antiviral protein as the zinc-finger
antiviral protein (ZAP) has been shown to inhibit HIV-
1 production by cells infected with CpG-enriched virus
genomes (42). Nevertheless, there are other hypotheses to
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Table 1. Methods for large-scale genome synonymous recoding
Method References






Codon-triplet bias usage (56)
Codons that could generate stop
mutations after a single nucleotide
substitution
(136)
explain the codon-pair bias. In particular, work with E. coli
has proposed that the size of the tRNA variable loop de-
termines whether the 3′ nucleotide adjacent to the codon
has a context effect (51), but others have claimed that the
P-site wobble position within the codon–anticodon inter-
action, and the A-site anticodon loop and acceptor stem
have a decisive effect on the observed genomic codon-pair
patterns (52). More recent studies in yeast have shown that
the wobble base pairing plays a critical role in whether a
codon-pair has an inhibitory effect on translation (53). This
work is in agreement with former studies, which would sup-
port the role of codon-pair usage bias. In addition, numer-
ous studies have offered evidence of the effect of codon-
pair usage bias on translational fidelity and rate (29,54,55).
Both codon-pair usage bias and dinucleotide content have
been incorporated into algorithms for gene optimization
or deoptimization (Table 1) (31). Furthermore, work per-
formed with the Salmonella flgM gene, which coordinates
flagellar gene expression and flagellum assembly, has shown
that mRNA translation is determined by a triplet-of-triplet
genetic code (56). That is, and similar to codon-pair us-
age, the efficiency of translating a particular codon is in-
fluenced by the sequence of the immediately adjacent flank-
ing codons. A model explains these codon-context effects
by suggesting that codon recognition by elongation factor-
bound aminoacyl-tRNA is initiated by hydrogen bond in-
teractions between the first two nucleotides of the codon
and anticodon, and then stabilized by base-stacking energy
over three successive codons (54). These data suggest that
the context of the genome sequence should consider codon
triplets in addition to codon-pairs and highlight the chal-
lenge of designing genes for maximal expression, whether
by natural selection or in the laboratory.
These studies illustrate the possible fitness costs of syn-
onymous genome recoding, which can be under strong se-
lection. As suggested previously, their importance in evo-
lution may be under-appreciated (57). Synonymous mu-
tations influence fitness in bacteria (8,11,18,57–67) and
viruses (36,68–89). In addition, synonymous rewriting of
protein-coding regions allows the encoded amino acid se-
quences to be retained, but it may remove other genetic
information, including hidden control elements embedded
within amino acid coding regions (56). We and others hy-
pothesize that synonymous genome recoding offers an op-
portunity to manipulate the microbial replication capacity
and biology.
SYNTHETIC GENOMICS
The ability to read (sequencing) and write (synthesis) DNA
sequences has greatly increased our capability to under-
stand and manipulate biological systems. Moreover, DNA
sequencing and synthesis are the fundamental technologies
in the development of synthetic genomics, which aims to de-
termine the fundamentals and design of a genome and engi-
neer novel biological functions. A genome is defined as syn-
thetic when all building blocks of the final DNA molecule
are generated by chemical synthesis (90,91). Synthetic tech-
niques for designing and manufacturing DNA offer the
promise of completely controlling an organism’s genetic in-
formation (92).
In the last decade, sequencing technologies have evolved
considerably. Following the development of several novel
DNA sequencing methods in the late 1990s and early 2000s
(93,94), different technologies have become commercially
available for so-called next-generation sequencing (NGS).
NGS in all branches of the tree of life has increased our
capability to understand biological systems and the interre-
lated genetic nature of different organisms. Knowledge re-
garding the genetic diversity of microorganisms, the micro-
biome, and human disease has also increased due to NGS.
Seven years ago, we started to sequence >15 petabases per
year (95). This wealth of sequence data also enhanced the
discipline of synthetic biology and genomics. In order to
better understand DNA sequence information, we need to
manipulate it and create new synthetic DNA reads. In con-
trast to the rapid development of DNA sequencing tech-
niques, the capability to synthesize DNA has not increased
at the same pace (90). Writing is much more difficult than
reading.
Synthetic genomics starts with short synthetic single-
stranded DNA fragments called oligonucleotides. Develop-
ments in the 1980s in polymerase chain reaction (PCR) al-
lowed the rapid assembly of overlapping oligonucleotides.
Kary Mullis and Michael Smith were awarded with the No-
bel Prize in Chemistry in 1993 for the invention of PCR and
the fundamental application of synthetic oligonucleotides
in DNA manipulation. In addition to other applications in
molecular biology, the invention of PCR and the chemical
synthesis of DNA oligonucleotides opened the door >30
years ago to synthetic genomics.
DNA chemical synthesis allows the synthesis of oligonu-
cleotides no more than 200 nucleotides in length (reviewed
in (90)). This is an intrinsic length limit based on phos-
phoramidite chemistry coupling efficiency. Yields of full-
length oligonucleotides can be affected by spurious depuri-
nation of the synthesized oligonucleotide during the acid
deprotection steps of the synthesis cycle and becomes es-
pecially problematic for longer oligonucleotide sequences.
The cost of column-based oligonucleotide synthesis has not
decreased substantially in the last decade. Custom com-
mercial oligonucleotide prices range from $0.05 to $0.50
per base depending on the scale of synthesis, the length of
the oligonucleotide, and the supplier. Moreover, in contrast
to custom pricing for sequencing, oligonucleotide prices
have increased in the last few years. Alternatively, the prices
have decreased for DNA synthesis via microarray-based
oligonucleotide synthesis. Compared to column-based tech-
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niques, array oligonucleotide synthesis can be consider-
ably cheaper. The problem with making oligonucleotides
from these array platforms for gene synthesis applications is
that they produce many more synthesis-related errors than
column-synthesized oligonucleotides (96,97). Minimizing
synthesis errors is crucial for large-scale genome synthesis.
One wrong base out of >1 million in an essential gene ren-
ders the genome of Mycoplasma mycoides (1.1 Mb) inactive
(98). Both the length and price of oligonucleotide synthesis
remain the main technical challenges to speeding up syn-
thetic genomics development.
Overlapping single-stranded DNA oligonucleotides 100–
200 nucleotides in length are designed to facilitate the as-
sembly and generation of double-stranded DNA. Several
oligonucleotides can easily be assembled by PCR or isother-
mal amplification to generate 1000–2000 base pair (bp)
DNA fragments (Figure 2). Using conventional cloning
methods, these synthetic DNA fragments can be cloned
into a bacterial plasmid vector and individual clones iso-
lated and sequenced by Sanger sequencing. Importantly,
both chemical DNA synthesis and PCR are error prone.
The probability of any given sequence containing a muta-
tion increases with the length of the DNA, which means that
more clones have to be sequenced to obtain a completely
correct DNA clone. Five to six overlapping PCR fragments
1000–2 000bp long can be assembled and cloned in a plas-
mid vector using the Gibson protocol to obtain up to 10–
15 kb DNA fragments (99). Via PCR recombination and
the isothermal cloning reaction, it has been shown to be
possible to synthesize the entire 16.3 kb mouse mitochon-
drial genome from 600 overlapping 60-nucleotide synthetic
oligonucleotides (100). Cloned fragments of this size can be
bought from commercial vendors at $0.10 to $0.50 per bp
depending on the fragment size and cloning vector. Com-
paring the prices for custom oligonucleotides and gene syn-
thesis, it may be worthwhile to use commercial DNA frag-
ment synthesis platforms. The Gibson protocol is proba-
bly the most commonly used method for assembling mul-
tiple pieces of DNA into larger constructs. This method
uses a one-pot isothermal technique, which utilizes an en-
zyme mixture containing a thermostable DNA polymerase,
DNA ligase and exonuclease to chew-back, anneal, and re-
pair adjacent overlapping DNA sequences in order to as-
semble the required DNA construct. More recent work has
updated and improved this method to further expand it
(101). Alternatively, the introduction of 1557 synonymous
TTA/TTG to CTA/CTG leucine codon changes across
200 kb of Salmonella typhimurium genomic DNA was per-
formed using stepwise integration of rolling circle amplified
segments (SIRCAS) (102). Genome recoding by SIRCAS
involves iterative recombination of recoded DNA segments
containing a selection marker (typically kanamycin or chlo-
ramphenicol resistance cassettes). After each step, one se-
lection marker is gained while the other is lost, providing a
readout for successful recoding.
The first full-genome synthetic reconstructions were per-
formed with RNA viruses because of their smaller genomes
(∼10 kb). RNA virus genomes can be constructed easily
and reasonably inexpensively using the method described
above (Figure 2). In 2002, the first complete synthesis of
a viral RNA genome was performed (103); in vitro tran-
scribed RNA generated from 7.5 kb of synthetic poliovirus
DNA representing its genomic sequence yielded infectious
virus particles after transfection of HeLa cell-free extract.
One year later, Smith and colleagues were able to gen-
erate the complete infectious genome of bacteriophage
X174 (5386 b) from a single pool of chemically synthesized
oligonucleotides in 14 days (104). Recently, additional vi-
ral RNA and DNA genomes were synthesized, up to a size
of 212 kb with the DNA genome of horsepox virus (105).
Horsepox virus is a DNA virus belonging to the genus Or-
thopoxvirus and is closely related to a group of viruses in-
cluding variola virus, the etiological agent of smallpox, and
vaccinia virus, the vaccine virus used to eradicate smallpox.
Variola virus no longer exists in nature, and the last nat-
urally occurring case of smallpox was in 1977. Synthetic
horsepox virus was generated by purchasing DNA frag-
ments of ∼30 kb each that collectively represent the entire
212 kb genome with some overlap between the fragments.
The most time-consuming part of the project was construc-
tion of the requested DNA fragments by the DNA synthesis
company (105).
The synthetic 30 kb DNA fragments of horsepox virus
were co-transfected into cells already infected with Shope
fibroma virus, which served as a helper virus to provide the
horsepox virus with the viral proteins it needed to conduct
DNA transcription and replication (106). However, we can-
not utilize this methodology to construct larger genomes
of other microorganisms, such as bacteria. An approach
taken by the Venter group was to reduce the genome of
M. mycoides by approximately 50% (107). Three rounds
of design, synthesis, and testing were necessary to pro-
duce JCVI-syn3.0 (531 kb), which has a genome smaller
than that of any autonomously replicating cell found in na-
ture. Gene-deletion methods allowed reduction of the E.
coli K-12 genome by 15% (108). Using this reduced E. coli
genome, Wang, Chin and colleagues developed a method to
replace genomic DNA with long (∼100 kb) synthetic DNA
through the in vivo excision of double-stranded DNA from
an episomal replicon by CRISPR/Cas9, coupled to lambda
red-mediated recombination and simultaneous positive and
negative selection (Figure 3) (109). Using this approach, this
group was the first to complete a 4-Mb synthetic version of
the E. coli genome (65). Synthetic DNA fragments approxi-
mately 10 kb in length were purchased from a DNA synthe-
sis company. Between 9 and 14 of these synthetic fragments
were assembled by homologous recombination in Saccha-
romyces cerevisiae using bacterial artificial chromosomes
(BACs) to generate 37 fragments 91–136 kb in length. These
37 BAC fragments contained Cas9 cleavage sites that al-
lowed its introduction into the previously reduced E. coli
K-12 genome.
The declared cost of the synthesis of the 212 kb genome
of horsepox virus was $100 000 (105). An international con-
sortium of 21 different institutions is synthetically recon-
structing all 16 chromosomes of S. cerevisiae. The consor-
tium has already described the synthesis of artificial yeast
chromosome synIII (273 kb) (110). Successively, five addi-
tional chromosomes have been reported (111–115). Similar
to E. coli, the redesigned yeast chromosomes had repetitive
sequences (tRNA genes, introns and transposons) removed
to allow genome reduction. In contrast, CRISPR has not
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Figure 2. Synthetic DNA oligonucleotide assembly and cloning. Overlapping oligonucleotides encoding a DNA duplex are successively assembled via
polymerase chain reaction (PCR) or isothermal amplification. Designed DNA duplex are now cloned in yeast or bacterial plasmid that after E. coli
transformation can be profusely amplified, sequenced and linearized for further cloning.
been used for progressive genome reduction. At the be-
ginning of this century, the first individual human genome
was sequenced (116,117). The Human Genome Project was
time-consuming and very expensive, but it accelerated the
development of new sequencing methods. Lowering DNA
synthesis costs should be one of the major goals in the field
of synthetic genomics (118).
SYNONYMOUS MUTATIONS AND MICROBE BIOL-
OGY
Aiming the construction of synthetic genomes will not only
enable the development of new technologies, but will also
allow an immense increase in knowledge in the biological
sciences. Large-scale synonymous recoding has broad ap-
plications for modulating diverse biological systems (34).
Synonymous recoding of synthetic genomes is an effective
alternative to conventional mutational analyses involving a
limited segment rather than broad-based genome recoding.
Furthermore, genome recoding may allow us to approach
biological questions that are very difficult to answer through
conventional methodologies (Table 2).
Recently, life was elegantly demonstrated to function
with a reduced number of synonymous sense codons (65).
An E. coli was created in which the entire 4-Mb genome
was replaced with synthetic DNA that no longer uses the
stop codon UAG (amber stop codon) and the two serine
codons UCG and UCA. By recoding 18 2014 codons, an
organism was created with 59 codons to encode the 20
amino acids. The previously essential bacterial tRNAs that
recognize these three codons can now either be deleted or
reassigned to recruit non-canonical amino acids (ncAAs)
into proteins synthesized in cells (109). The synthesis of a
57-codon E. coli genome is also under way (119). NcAAs
are those not naturally encoded or found in the genetic
code of any organism. Reassigned tRNAs are being used
to expand the genetic code by enabling the co-translational
and site-specific incorporation of diverse ncAAs into pro-
teins synthesized in cells (120). To expand the genetic code,
an orthogonal aminoacyl-tRNA synthetase–tRNA pair is
used to direct the incorporation of an ncAA into proteins
through an unassigned codon (e.g. the amber stop codon
UAG or the two serine codons UCG and UCA) introduced
at the desired site in a gene of interest (121–123). The pos-
sibility of integrating ncAAs with diverse structures and
properties into proteins in diverse microorganisms will al-
low proteins to be engineered with alternative structures
and functions, and to develop new therapeutic agents (see
below) (121).
The combination of DNA synthesis, lambda red recom-
bination (a technique based on homologous recombina-
tion), and CRISPR-based editing, which allowed the gen-
eration of a full synthetic E. coli genome, can be used to
explore other aspects of bacterial biology. The introduc-
tion in Caulobacter ethensis of 133 313 synonymous sub-
stitutions that recoded 123 562 codons resulted in the in-
activation of 98 genes (124). Interestingly, 27 of the for-
mer genes contained non-coding control features embedded
within protein-coding sequences. The functional basis of
this gene inactivation is still poorly understood. Transcrip-
tional and/or translational control signals at the termini of
coding sequences, as well as imprecise genome annotations,
may be the underlying cause of gene inactivation. The ex-
pression of several hundred synonymous mutants of green
fluorescent protein (GFP) in E. coli revealed that many syn-
onymous variants reduce bacterial fitness (18). The underly-
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Figure 3. Synthetic DNA generation of a full-length bacterial genome. (A) Oligonucleotides (100–200 nucleotides long) are recombined by PCR, cloned
in a bacterial plasmid, and sequenced. Synthetic DNA fragments from plasmids of ∼10 kb (pink, green, and blue) are assembled by homologous recombi-
nation in Saccharomyces cerevisiae using bacterial artificial chromosomes (BACs) to generate a length of ∼100 kb. BAC fragments contain Cas9 cleavage
sites (black arrows) that allow them to be liberated and to replace genomic bacterial DNA by homologous recombination. The double-selection cassette
(−1, +1) (e.g. rpsL-kanR) ensures the integration of the synthetic DNA, and the double-selection cassette (−2, +2) on the genome ensures the removal
of the corresponding wild-type DNA. (B) Different BAC fragments have homologous overlapping sequences and corresponding selection cassettes for
sequentially and iteratively replace the bacterial genome in the precise genome location.
ing mechanism is independent of translation but depends on
the production of toxic mRNA molecules, suggesting that
translation-independent RNA toxicity may be an unrecog-
nized obstacle in bacterial gene expression.
Due to the shorter genomes of RNA viruses, synthetic
genomics has been employed much more often to explore
diverse aspects of virus biology. Similar to what has been
found in C. crescentus, large-scale synonymous recoding
has allowed the identification of diverse features encoded
within virus genomes (Table 2). Large-scale synonymous re-
coding of viral genomes has uncovered new antiviral mech-
anisms within the innate immune response (125). Com-
pared to the host cell preference, the human immunode-
ficiency virus type 1 (HIV-1) genome contains extremely
high frequencies of A nucleotides (between 31.7% and 38%),
low G/C content, and suboptimal codon usage, partic-
ularly within the gag (virus structural proteins) and pol
(virus enzymes) sequences (126,127). This uncommon rare
codon bias favors A/U in the third codon position. Schlafen
(SLFN) genes contain a subgroup of interferon-stimulated
early-response genes that are directly induced by pathogens
via the interferon regulatory factor 3 pathway (54). Hu-
man SLFN11 has been described as a novel host restriction
factor that suppresses HIV-1 protein synthesis in a codon
usage-dependent manner (128). SLFN11 utilizes the unique
viral codon bias towards A/U nucleotides. Consequently,
wild-type (WT) HIV-1 is affected by SLFN11, but not re-
coded viruses containing HIV-1 structural gag sequences
optimized for human cell expression (i.e. without A/U in
the third position) (128). Using synonymous mutagenesis,
CpG suppression was recently shown to be essential for
HIV-1 (50). The effect of CpG dinucleotides is exerted post-
transcriptionally and independent of translation efficiency.
A zinc-finger antiviral protein (ZAP) has been identified
that inhibits virion production by cells infected with CpG-
enriched HIV-1. These results suggest that ZAP utilizes
host CpG suppression to identify non-self RNA. Similarly,
large-scale synonymous recoding of viral genomes allows
the identification of viral sequence patterns, including CpG
content, detected by innate immune pathways in different
viral systems, such as influenza virus (48,129), echovirus
(130), foot and mouth disease virus (131), and simian im-
munodeficiency virus (SIV) (77).
RNA virus populations are genetically very heteroge-
neous. Genetic variation is generated by the accumulation
of mutations during replication and their rearrangement by
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Table 2. Synonymous recoding as a new tool for exploring microbial biology
Explored features Microbe Targeted genome region References
Reduced number of synonymous sense
codons
E. coli Full-genome (65,121)
Specific mRNA structures required for
replication
Poliovirus P2 and P3 (138,139)
Virus genome cis-inhibitory signal
sequences relevant to complex viral
functions
Respiratory Syncytial Virus NS1 and NS2 (153)
Non-coding control features embedded
within protein-coding sequences
C. ethensis Full-genome (124)
Immune innate response Influenza Virus Segment 5 (48,50,77,128–130)
HIV-1 Env and Gag
SIV Gag and Pol
Echovirus 7 VP3, 3C, and 3D
Codon usage and the temporal regulation
of viral gene expression
SIV Herpesvirus Env ORF57 (141)
Genome position in sequence space,
evolutionary trajectory, and pathogenicity
Poliovirus Capsid (134–137)
Coxsackie virus Capsid
Influenza Virus Polymerase and
Haemagglutinin
HIV-1 Protease
genetic recombination, and genome segment reassortment
in the case of segmented genomes (132). Unlike DNA poly-
merases, RNA viruses lack proofreading activity, resulting
in an estimated error rate during replication of 10−3 to 10−5
mutations per nucleotide per replication cycle. This high
mutation rate generates a virus population composed of
closely related mutant spectra or mutant clouds termed vi-
ral quasispecies (133). The quasispecies dynamics of RNA
viruses are intimately related to both viral disease and an-
tiviral treatment strategies. One unexplored aspect of the
genetic architecture of RNA viruses is how codon choice
influences population diversity and evolvability. In order to
explore this aspect of RNA virus biology, the quasispecies
structure of a poliovirus containing 934 synonymous sub-
stitutions randomly introduced in the 2643-nucleotide-long
capsid coding region (72) was compared to the WT virus
(134). As expected, the recoded virus explores a different
sequence space and gives rise to a distinct spectrum of mu-
tants. Interestingly, mice infected with the synonymously re-
coded poliovirus exhibit delayed and decreased mortality
compared to mice inoculated with the same doses of WT
virus, suggesting that a virus quasispecies structure and mu-
tant spectrum impact viral pathogenesis. This attenuated
phenotype exhibited by the recoded virus suggests a pos-
sible new strategy for the generation of live attenuated vac-
cines (34,135). Another strategy explored to attenuate cox-
sackie B3 and influenza A viruses has been to redirect their
evolutionary trajectories towards detrimental regions of se-
quence space (136). Viral genomes were synonymously re-
coded to harbor more serine and leucine codons that could
generate stop mutations after a single nucleotide substi-
tution (136). These engineered viruses generate more stop
codons and result in significant losses in viral fitness. More
recently, synonymous virus genome recoding has been used
to investigate how the HIV-1 position in sequence space
defines its mutant spectrum. To this end, a synthetic virus
was generated carrying a reengineered protease sequence in-
cluding 13% of synonymous mutations (137). WT and re-
coded viruses were propagated in the presence of HIV-1 pro-
tease inhibitors (PIs). Ultradeep sequence clonal analysis
revealed that both viruses harbor previously described mu-
tations conferring resistance to PIs. However, the WT and
recoded HIV-1 proteases had different resistance variant
repertoires, indicating that the HIV-1 protease position in
sequence space delineates the evolution of its mutant spec-
trum. Importantly, in both poliovirus and HIV-1, synony-
mously recoded viruses did not have a reduced replication
capacity compared to the WT virus.
Adenoviruses are DNA viruses broadly employed as vec-
tors for human gene therapy and vaccines. In particular,
single-stranded adenovirus-associated virus (AAV) has the
unique capacity for site-specific integration into a transcrip-
tionally silent region of the human genome. However, AAV
Rep 78 protein has an inhibitory effect on adenovirus repli-
cation. In order to explore the inhibitory mechanism of
Rep78, synonymous recoding was performed on the 1866-
nucleotide-long Rep genomic segment (76). The genetically
recoded AAV Rep gene permitted the identification of a
135-bp long cis-acting element in the Rep sequence. Reengi-
neering this cis-acting element overcame Rep’s inhibitory ef-
fects on adenovirus replication. Reengineered Rep is readily
tolerated, facilitating the development of improved adeno-
based gene-therapy vectors. Large-scale codon optimiza-
tion of two DNA viruses, adenovirus and papilloma virus,
has also aided in our understanding of how these viruses
increase their fitness, immunogenicity, and oncogenic po-
tential (81,83). The utility of synonymous recoding to iden-
tify the locations of critical DNA or RNA sequence signals
was also demonstrated with poliovirus. The introduction of
2256 synonymous substitutions into the 6 606-nucleotide-
long non-structural protein-coding region of poliovirus al-
lowed the discovery of two 75-nucleotide-long unique, func-
tionally redundant RNA elements, which are separated by
150 nucleotides, in the 3′-terminal coding sequence of po-
liovirus RNA polymerase (138). Similarly, massively re-
coded poliovirus has allowed the identification of conserved
synonymous sites and local secondary RNA that play a role
in determining virus packaging (139).
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Another example of the utility of large-scale synony-
mous recoding is the identification of how codon usage
is implicated in the temporal regulation of gene expres-
sion. A number of viruses are able to maintain life-long in-
fections in their natural host despite strong host immune-
surveillance measures. Persisting viruses can be found in the
lenti-retroviruses (e.g. HIV-1/SIV), herpes, polyoma, pa-
pilloma, parvo, and adenovirus families. Persisting viruses
exquisitely regulate their gene expression in a time-based
manner. In many cases, such as HIV-1, structural proteins
are made late in the viral replication cycle, and expression of
these late gene products is typically induced by viral transin-
ducers made earlier in the viral replication cycle (140). In-
triguingly, structural gene products of different members of
human persisting viruses exhibit a marked bias of codon
usage compared to the codon usage of the human exome
(141). In HIV-1/SIV, the viral protein Rev acts as a transin-
ducer. Rev protein interacts with a highly structured ele-
ment in the envelope gene (env), referred to as the Rev-
responsive element (RRE). In the absence of Rev, mRNAs
of the HIV-1 late structural genes (e.g. Env protein) are re-
tained in the nucleus, preventing their translation. Env has
unusual codon usage that is different from that of the host
cell. Synonymous recoding of env has demonstrated that
Rev induction of Env protein expression depends on its bi-
ased codon usage. Rev inducibility was lost when 10.5% of
the env codons were synonymously replaced (141). Anal-
ogous results were obtained when this approach was used
with rhesus monkey rhadinovirus (RRV), a member of the
herpesvirus family, ORF57 transinducer (141). ORF57 in-
duces the late expression of RRV structural glycoprotein
H (gH), but this inducibility was lost when 14.3% the gH
codons were replaced with synonymous codons. Interest-
ingly, the transinducibility of Env expression can be regu-
lated by ORF57 instead of Rev by modifying env to make
it better resemble the codon use of gH. Similarly, the de-
pendence of gH on ORF57 expression can be changed to
Rev dependence by changing the nature of its codon usage.
These results suggest that persisting viruses use poor codon
usage that is biased in a distinctive way to temporally reg-
ulate late expression of structural gene products. Coupling
synthetic genomics and synonymous recoding is an inter-
esting and effective strategy for modulating diverse biolog-
ical systems, and a possible alternative to conventional mu-
tational analysis involving a limited number of nucleotide
substitutions.
SYNONYMOUS MUTATIONS AND MICROBE THERA-
PEUTICS
Synthetic genomics is pushing a new era of medicine via
the genetic programming of living cells. A recent exam-
ple is bacteria. An E. coli strain containing a synchronized
lysis circuit that colonizes tumors and undergoes intratu-
moral quorum lysis was engineered to locally release an en-
coded nanobody antagonist of CD47, an anti-phagocytic
receptor overexpressed in several human cancers (142). This
construct allows for the combined local delivery of an im-
munotherapeutic agent along with immunestimulatory bac-
terial lysis adjuvants to stimulate antitumor immunity and
promote tumor regression.
An obvious application of synonymous nucleotide recod-
ing is codon optimization to increase protein expression
and improve the production of therapeutic antibodies, cy-
tokines, or fusion proteins (reviewed in (143)). However,
in mammalian cells, codon optimization is not evident be-
cause, as noted previously in this review, not all synonymous
codon mutations are neutral.
The approach of reducing expression by intentional in-
troduction of suboptimal synonymous codons has been
used extensively with viruses (Table 3). The first com-
plete synthesis of an organism’s genome was performed
with poliovirus (103). Similarly, the first large-scale syn-
onymous recoding of a genome was carried out with po-
liovirus. Simultaneously, Burns et al. and Mueller et al.
demonstrated the viability of synonymously recoding the
poliovirus genome (72,79). Using the Sabin type 2 oral po-
liovirus vaccine strain, Burns et al. reengineered the capsid
coding region of poliovirus by replacing degenerate codons
for nine amino acids with corresponding non-preferred syn-
onymous codons. Up to 542 synonymous substitutions were
introduced among the 2 555 nucleotides of the virus capsid
region. Quantifying virus yields in HeLa cells and plaque
areas (visible structures formed within a cell culture by virus
cell destruction), these authors demonstrated that the repli-
cation capacity of the virus was reduced up to 98%. When
recoded viruses were serially propagated in HeLa cells to
test their stability, viral evolution was demonstrated by in-
creased virus yields, increased plaque sizes, and mutated ge-
nomic sequences (79). Mueller et al. were also able to reduce
the replication capacity of the Mahoney strain of poliovirus
by introducing suboptimal synonymous codon changes in
the virus capsid coding region (72). When this suboptimal
recoded virus was inoculated in poliovirus CD155 trans-
genic mice, the variant presented a neuroattenuated pheno-
type. Attenuation of the classical oral poliovirus vaccine is
based on very few point mutations, which can revert to vir-
ulence after a few rounds of viral replication (144). These
pioneering results obtained with recoded polioviruses sug-
gest that codon-usage in recoded viruses may be much more
stable than most RNA virus point mutants, and could pos-
sibly enable the development of live attenuated RNA virus
vaccines with superior genetic stability. Moreover, synony-
mous recoding does not affect the viral amino acid sequence
and its subsequent antigenicity.
Large-scale synonymous codon usage recoding has also
been used to obtain safe live attenuated vaccines for ar-
boviruses, such as Chikungunya virus (74) and tick-borne
encephalitis virus (85). An interesting approach to develop-
ing new arbovirus vaccines is to codon-optimize the virus
to grow in insect cells and deoptimize it to reduce its repli-
cation capacity to non-viability in mammalian cells (75).
Viruses that are non-viable in mammalian cells could still be
grown in insect cells, implying that one might design a vac-
cine that combines features of live attenuated viruses with
features of inactivated viruses. Analogously, work with SIV
has shown that codon optimization of gag and pol results
in a 100-fold decrease in virus replicative capacity (77). Re-
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Table 3. Examples of microbe attenuation by synonymous genome recoding
Microbe Targeted genome region Method References
Streptococcus pneumoniae Pneumolysin Codon-pair usage (64)
Methylobacterium extorquens Formaldehyde-activating enzyme Codon bias usage (62)
Salmonella enterica Ribosomal protein S20, L- -glutamyl
phosphate reductase
Codon bias usage (57,58)
Escherichia coli Lac-Z, green florescence protein,
Beta-lactamase
Codon bias usage (11,18,60,61)




Echovirus 7 VP1, VP2, 3C, 3D Dinucleotide frequency (37,86)





Human immunodeficiency virus type 1 Protease Codon-pair usage (69)
Simian immunodeficiency virus Gag, Pol Codon bias usage (77)
Chikungunya virus Non-structural proteins: nsP1, nsP4
Structural proteins: E2, E1
Codon bias usage (74)
Dengue virus E, NS3, NS5 Codon-pair usage (75)
Zika virus E, NS1 Codon-pair usage (89)
Tick-borne encephalitis virus NS5 Codon bias usage (85)
Respiratory syncytial virus NS1, NS2, N, P, M, SH, G, F, L Codon-pair usage (87)
Porcine reproductive and respiratory
syndrome virus
Envelope GP5 Codon-pair usage (73)
Vesicular stomatitis virus L1 Codon-pair usage (78)
Papillomavirus Oncogenes E6, E7 Codon bias usage (83)
Marek’s disease virus UL54/ICP27, UL49/VP22, UL30 Codon-pair usage (82,84)
Adenovirus Fiber Codon bias usage (81)
Cucumber mosaic virus Coat protein Codon bias usage (70)
markably, the recoded virus has a reduced ability to stim-
ulate type I interferon and possibly attenuated pathogenic
potential.
Wimmer et al. demonstrated that genome recoding using
underrepresented codon pairs can also result in poliovirus
virus attenuation (36). The introduction of 407 synonymous
substitutions into the poliovirus (Mahoney) capsid coding
region, which generates underrepresented codon pairs, re-
sulted in decreased rates of virus protein translation, re-
duced replication capacity in HeLa cells, and attenuation in
mice (36). Similar results were obtained with another vari-
ant carrying 224 synonymous changes in the same region
of the viral genome. These polioviruses were used to im-
munize mice and provided protective immunity after chal-
lenge. Codon-pair deoptimization has been performed in
a number of viruses, including negative RNA viruses such
as influenza virus (71, 80) and respiratory syncytial virus
(RSV) (87), vesicular stomatitis virus (78), positive RNA
viruses such as porcine reproductive and respiratory syn-
drome virus (73), dengue virus (75), zika virus (89), HIV-
1 (69), the plant cucumber mosaic virus (70), and DNA
viruses such as Marek’s disease herpesvirus (82,84). Syn-
onymous codon pair deoptimization has not been restricted
to viruses and has been applied to other microorganisms
(Table 3) (64).
Synonymously increasing the frequencies of CpG and
UpA dinuclotides has also been explored as an alter-
native method of virus attenuation. Most mammalian
RNA and small DNA viruses suppress genomic CpG
and UpA dinucleotide frequencies, apparently mimicking
host mRNA composition. Increasing the CpG and UpA
dinucleotide frequencies attenuated poliovirus, influenza
virus and echovirus 7 (another picornavirus like poliovirus)
(37,48,68,86). As discussed previously, sometimes increased
CpG and UpA dinucleotide frequencies and codon-pair de-
optimization are not easily distinguished (43).
Recoding viral genomes by numerous synonymous but
suboptimal substitutions can be a new source of live at-
tenuated vaccine candidates. The hypothesis is that large-
scale recoded viruses should be genetically stable because
deattenuation may require dozens or hundreds of reversions
(36). However, their genetic stability under selective pres-
sure is largely unknown. Attempts to evaluate phenotype
stability have resulted in interesting results. Codon pair de-
optimized versions of RSV were generated and presented an
attenuated and temperature-sensitive phenotype (88). When
recoded viruses were serially propagated in tissue culture at
progressively increasing temperatures, an RSV variant con-
taining 2 692 synonymous mutations in 9 of 11 open read-
ing frames (ORFs) did not lose temperature sensitivity, re-
mained genetically stable, and was restricted at tempera-
tures of 34/35◦C and above. However, a variant contain-
ing 1 378 synonymous mutations solely in the polymerase L
ORF quickly lost substantial attenuation. Sequence analy-
sis of virus populations after tissue culture passages iden-
tified many different potentially deattenuating mutations in
the L ORF, as well as many others appearing in other ORFs
(88). These results emphasize, again, the rapid evolution of
RNA viruses and the necessity of stability studies to obtain
improved synthetic virus vaccine candidates.
The recent generation of a full synthetic E. coli genome
(65) has opened up unexplored possibilities for designing a
new generation of bacterial live attenuated vaccines. Proof
of the concept has been shown with Streptococcus pneu-
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moniae (64). Codon pair recoding of S. pneumonia pneu-
molysin gene has resulted in strains that are less virulent
in mice than the WT. One particular aspect of the new syn-
thetic E. coli genome is that it uses only 61 of the 64 available
codons in its protein-coding sequences, replacing two ser-
ine codons and one stop codon with synonyms (65). These
deleted codons can now be reassigned to recruit ncAAs
beyond the usual 20 used by most living cells (145). The
genome of S. typhimurium has also been found to have two
fewer codons; 1 557 synonymous leucine replacements were
performed to delete two leucine codons (102). Engendered
S. typhimurium can be used as a cell-based technology in
the human gut. Now ncAAs can take part in chemical re-
actions that natural proteins cannot perform. An expanded
genetic code might engender next-generation biopharma-
ceuticals (146). An enlarged amino acid repertoire will al-
low proteins to have new or modified functions, providing
ample opportunities for innovative or improved medicines.
Current pipelines involve the areas of half-life extension,
antibody-drug conjugates (ADCs), bi-specific antibodies,
modular chimeric antigen receptor T cell therapy (CAR-T),
vaccine development, and expanded applications for diag-
nosis and bio-compatible materials (146). These new bio-
pharmaceuticals are being explored in cancer and inflam-
matory, autoimmune, and metabolic diseases (121).
Synonymous codon compression and ncAAs can also be
employed to develop viral attenuated vaccines (121). The in-
troduction of amber codons into the genomes of hepatitis D
virus, HIV-1 and influenza A has allowed the generation of
viral genomes that replicate only in cells that can decode the
amber codon (147–149). These viruses can be replicated in
cells that contain orthogonal aminoacyl-tRNA synthetase
and orthogonal tRNACUA. However, they are attenuated in
cells that cannot suppress the amber codon. With the in-
troduction of several amber codons throughout the viral
genome, the frequency of revertants can be greatly reduced
(148). However, safety studies should be performed because
a read-through of stop codons can occur in some cell types
(150).
OUTLOOK FOR THE FUTURE
Synthetic genomics and synonymous genome-wide rewrit-
ing will decode essential genome functions and allow the de-
sign of improved microorganisms for industrial and health
applications. Although significant advances have been made
in this field, it is still necessary to elucidate the exact mecha-
nistic foundations underlying the contributions of synony-
mous substitutions to phenotype. Unraveling the funda-
mental mechanistic impact of synonymous substitutions is
essential to support the use of synonymous recoding in an
array of biological and clinical contexts. Despite this re-
view focusing on viruses and bacteria, the work can pio-
neer the study of the impact of synonymous substitution
on human diseases. As exemplified by the development of
new and massive DNA sequencing methodologies, cheap
and accurate DNA synthesis will be necessary to achieve
ambitious objectives. The synthesis of relatively small DNA
fragments (<10 kb) is currently straightforward. However,
new and easier methodologies should be developed to as-
semble larger pieces of synthetic DNA (e.g. DNA cloning
and recombinant protocols). These new methodologies will
be necessary if we want to synthetically engineer eukaryotic
genomes. Without a doubt, synthetic genomics will greatly
impact new diagnostics and therapies, as well as basic re-
search.
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